FEMALE PATTERN HAIR LOSS, ANDROGENIC ALOPECIA
Clinical trials for FEMALE PATTERN HAIR LOSS, ANDROGENIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new FEMALE PATTERN HAIR LOSS, ANDROGENIC ALOPECIA trials appear
Sign up with your email to follow new studies for FEMALE PATTERN HAIR LOSS, ANDROGENIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hair loss treatment DA-001 enters Large-Scale human trial
Disease control Not yet recruitingThis study tests whether a treatment called DA-001 can reduce hair shedding and help hair grow back in people with certain types of hair loss, including telogen effluvium and female or male pattern baldness. About 1120 adults will apply the treatment as directed and be monitored …
Matched conditions: FEMALE PATTERN HAIR LOSS, ANDROGENIC ALOPECIA
Phase: PHASE2, PHASE3 • Sponsor: Applied Biology, Inc. • Aim: Disease control
Last updated May 17, 2026 08:05 UTC
-
New drug aims to regrow hair in women with pattern baldness
Disease control Not yet recruitingThis study tests a new medicine called N1087 for women with female pattern hair loss. About 372 women will take either the drug or a placebo daily for 24 weeks. The goal is to see if the drug increases hair density and thickness in the scalp area. Researchers will also check safe…
Matched conditions: FEMALE PATTERN HAIR LOSS, ANDROGENIC ALOPECIA
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 17, 2026 08:02 UTC